Andrei Balandin

Andrei Balandin practices at Ironwood Cancer & Research Centers in Glendale, Arizona.

Andrei Balandin's NPI, 1427225986, was assigned on May 14, 2008. Andrei Balandin holds Arizona license 49189.

Andrei Balandin's primary practice is Ironwood Cancer & Research Centers, at 5810 W Beverly Ln, Glendale, AZ 85306 in Maricopa County. The practice phone is (480) 821-2838.

Andrei Balandin's primary practice is Ironwood Cancer & Research Centers in Glendale, Arizona. Andrei Balandin is also affiliated with Banner Thunderbird Medical Center. The medical group on file is Ironwood Cancer & Research Centers. Dmand AI also links Andrei Balandin to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Andrei Balandin practices, 2 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Andrei Balandin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Andrei Balandin is licensed in Arizona.

CMS data shows 104,668 Medicare services from Andrei Balandin across 33 procedure codes in 2024, for 492 Medicare patients. Medicare paid $721,039 for them.

CMS counts 492 Medicare patients who saw Andrei Balandin in 2024. The largest group is 65 to 74, with 218 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Andrei Balandin's median patient age at 69, with 57% women.

In 2024, Andrei Balandin wrote 653 Medicare Part D claims for 115 patients. 60% of them were for generic drugs. CMS names the drug for 511 of them, across 23 drugs with 11 or more claims each, at $1,197,361 in total drug cost. In 2023, CMS named 505 claims across 20 drugs.

Andrei Balandin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Andrei Balandin as offering telehealth.

Dmand AI links 1 paper to Andrei Balandin in 2012. Andrei Balandin's most frequent co-authors are Federico Laurel Ampil, MD, Glenn Morris Mills, MD and John Ponugupati, MD.

CMS Open Payments shows 456 general payments to Andrei Balandin from 55 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 84% of the total. Bristol-Myers Squibb Company paid the most, $2,154.